SIX:RO

Roche Holding AG · SIX · Healthcare · CHF · FY for 2025

Figures on this page computed 2026-11-08 13:05 UTC

Last close

n/aCHF

Market data

  • 24.7xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • computed
    • Computed from the filing for 2025
  • 25.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 20.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 22.9%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.98Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 2.6%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • computed

All from 100

lens 2 of 9

Sales

117
2016-12-31 to 2025-12-31100 at the start117
Sales: 100.00 on 2016-12-31 to 116.87 on 2025-12-31, up 17%.

Profit

135
2016-12-31 to 2025-12-31100 at the start135
Profit: 100.00 on 2016-12-31 to 134.50 on 2025-12-31, up 35%.

Shares in issue

93.4
2016-12-31 to 2025-12-31100 at the start93.4
Shares in issue: 100.00 on 2016-12-31 to 93.37 on 2025-12-31, down 7%.

Sales is at 117, Profit is at 134, Shares in issue is at 93, against 100 in 2016.

Sales is at 117, Profit is at 134, Shares in issue is at 93, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales, where the first year is 100117
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Profit, where the first year is 100135
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Shares in issue, where the first year is 10093
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.